Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Carbon Nanotube-Based Device Efficiently Transports Nucleic Acids into Cell Cultures

By LabMedica International staff writers
Posted on 25 Apr 2016
A novel device based on carbon nanotubes arranged in "honeycomb-like" structures was used to safely and efficiently transfer genetic material into cultures of different types of human and animal cells.

The introduction of nucleic acids into mammalian cells is a crucial step toward elucidating biochemical pathways and for modifying gene expression and cellular development in immortalized cells, primary cells, and stem cells. More...
Current transfection technologies—such as electrical pulse, gene gun inoculation, and employing viral infection—are time consuming and limited by the size of the genetic cargo that can be transferred, the inefficient introduction of test molecules into large populations of target cells, and the cytotoxicity of the techniques.

Investigators at the University of Rochester (NY, USA) have reported the development of a novel method of introducing genes and biomolecules into tens of thousands of mammalian cells through an array of aligned hollow carbon nanotubes. The device was prepared using the process of chemical vapor deposition that resulted in a structure resembling a nano-sized honeycomb consisting of millions of densely packed carbon nanotubes with openings on both sides of a thin disk shaped membrane.

In a paper published in the April 5, 2016, online edition of the journal Small, the investigators described using the device to culture a series of different human and animal cells. After 48 hours, the cells were bathed in a DNA-enriched liquid medium. The carbon nanotubes acted as conduits drawing the genetic material into the cells in a mild fashion that preserved 98% of the cells with 85% successfully transfected with the new genetic material.

"This represents a very simple, inexpensive, and efficient process that is well tolerated by cells and can successfully deliver DNA into tens of thousands of cells simultaneously," said senior author Dr. Michael Schrlau, assistant professor of engineering at the University of Rochester.

Related Links:
University of Rochester


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.